Senior Care Pharmacy Coalition (SCPC) Suggests Two PBM Transparency Refinements to Senate Finance Committee Drug Pricing Bill
Washington, DC – In previously noting that capping Medicare beneficiaries’ out-of-pocket costs as low as possible is a primary long-term care (LTC) pharmacy advocacy priority as Congress debates drug pricing reform legislation, the Senior Care Pharmacy Coalition (SCPC) also recommended two pharmacy benefit manager (PBM) transparency provisions be included in the pending Prescription Drug Pricing Reduction Act of 2019 (S. 2543).
“SCPC applauds Chairman Grassley and Ranking Member Wyden for already including in the bill disclosure provisions for PBMs to the Centers for Medicare and Medicaid Services (CMS) — and for CMS to the public — which would significantly benefit consumers,” stated Alan G. Rosenbloom, President and CEO of SCPC.
As the legislation moves forward, Rosenbloom said SCPC recommends two additional policy refinements related to PBM transparency:
- More marketplace competition must be a companion to additional PBM transparency, as transparency alone will not address the increasingly oligopolistic nature of the pharmaceutical marketplace and LTC pharmacies’ place within it;
- Provisions that require reporting of information specific to retail pharmacies should logically be expanded to require reporting of data specific to LTC pharmacies.
“We look forward to working with the Chairman, Ranking Member and members of the Senate Finance Committee to advance a positive, bipartisan bill and improve it for the benefit of the nation’s independent long-term care pharmacies and the elderly, vulnerable patients they serve,” Rosenbloom concluded.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
LTC pharmacies said this would happen. New data says they were right.
By Donna Shryer // Published July 18, 2026 in McKnight’s Long-Term Care News Long-term care pharmacies predicted a steep reimbursement hit from the Inflation Reduction Act’s Medicare drug pricing changes. Now they say they have the data confirming it. A new analysis of member financial data shows reimbursement for drugs subject to the law’s negotiated […]
-
New Analysis Confirms Drug Pricing Changes Hurt LTC Pharmacies, Reinforces Need for Sustainable Payment Reform
Washington, D.C. (July 16, 2026)— A new analysis of member provided financial data confirms what the Senior Care Pharmacy Coalition (SCPC) has warned: the Inflation Reduction Act’s (IRA) Medicare drug pricing provisions that went into effect in 2026 have significantly reduced reimbursement for long-term care (LTC) pharmacies, threatening their financial sustainability and the benefits of […]
-
LTC Pharmacies Double Down On Call For PBM Contract Negotiation Reform
Lauren Brensel // Inside Health Policy – July 23, 2026 A group representing long-term care pharmacies is reminding policymakers of the negative impacts that result from problematic contract negotiations with pharmacy benefit managers, asking CMS to help alleviate pharmacies’ disputes with the three largest PBMs by embracing a series of reforms. LTC pharmacy services like […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.